Individuals dying from COVID-19 may have in common …a parasite. Preexisting parasitic infection fully explains the lack of available immune components necessary to fight this virus. Before dismissing this theory as a crazy notion, please consider the overwhelming evidence.
Older individuals are more susceptible to COVID-19. Hypertension and diabetes are the very first diseases of age, although those afflicted are not always older. Obesity is another factor, not always age related. A parasite can cause each of these.
The latest studies on aging suggest an epigenetic rather than a genetic causation. The mechanism responsible for both would entail lack of specific amino acids. Even perfect RNA cannot build protein (immune or otherwise) without the availability of all needed amino acids.
Aging is now thought to compose a specific form of protein starvation. Many very old individuals do appear to be starving. That older individuals may become obese has served to disguise the starvation component of aging. Parasitic drag explains it all.
Prokaryotic animals such as bacteria have ability to produce all of their own amino acids. Eukaryotes, such as humans, can only internally produce some of these. That bacteria have ability to produce every amino acid does not preclude specific bacteria from utilizing underutilized amino acids especially during periods of accelerated growth. Over time, this may become a preference.
Human obesity seems to involve amino acid consumption by rogue bacteria. As humans will always well absorb fats and carbohydrates the end result is obesity. It is now a given that specific bacteria hold responsibility for obesity. Obesity has been documented as transferred from one individual to another by fecal transplant.
An offending family of bacteria has been identified. Unfortunately, multiple species exist within this family and each is resistant to a different antibiotic.
As a pharmacist, my focus is on getting active compounds into the body. My undergraduate degree is biology, so I‘m attuned to the microbiome. The challenge becomes getting specific nutrition past unspecified parasitic bacteria colonizing the human gut. Simply adding more of missing amino acid nutrition will worsen the condition by stimulating the growth of parasitic bacterial.
The missing amino acids identified; a nutritional supplement was formulated that prevented bacterial absorption in the gut. Clinical trials were completed in 2013. An entire science, Microbolics, was developed over the last seven years while awaiting final action by the United States Patent and Trademark Office. (C)
Commercial availability of a nutritional aid to combat COVID-19 simply awaits an end to Federal inaction.
No comments:
Post a Comment